AC
Armistice Capital’s Pacira BioSciences PCRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-1,892,000
| Closed | -$73.1M | – | 245 |
|
|
2022
Q4 | $73.1M | Buy |
1,892,000
+300,000
| +19% | +$11.6M | 1.27% | 18 |
|
|
2022
Q3 | $84.7M | Buy |
1,592,000
+1,000,000
| +169% | +$53.2M | 1.47% | 13 |
|
|
2022
Q2 | $34.5K | Buy |
592,000
+68,000
| +13% | +$3.96K | 0.6% | 44 |
|
|
2022
Q1 | $40M | Sell |
524,000
-788,000
| -60% | -$60.1M | 0.77% | 37 |
|
|
2021
Q4 | $78.9M | Buy |
1,312,000
+376,000
| +40% | +$22.6M | 1.29% | 13 |
|
|
2021
Q3 | $52.4M | Buy |
+936,000
| New | +$52.4M | 0.89% | 25 |
|
|
2019
Q2 | – | Sell |
-1,072,000
| Closed | -$40.8M | – | 74 |
|
|
2019
Q1 | $40.8M | Buy |
+1,072,000
| New | +$40.8M | 2.23% | 8 |
|
|
2018
Q2 | – | Sell |
-726,671
| Closed | -$22.6M | – | 77 |
|
|
2018
Q1 | $22.6M | Buy |
726,671
+398,671
| +122% | +$12.4M | 1.73% | 22 |
|
|
2017
Q4 | $15M | Buy |
328,000
+40,000
| +14% | +$1.83M | 1.49% | 18 |
|
|
2017
Q3 | $10.8M | Buy |
+288,000
| New | +$10.8M | 1.27% | 22 |
|
|
2017
Q1 | – | Sell |
-400,000
| Closed | -$12.9M | – | 50 |
|
|
2016
Q4 | $12.9M | Buy |
400,000
+132,000
| +49% | +$4.26M | 3.06% | 4 |
|
|
2016
Q3 | $9.17M | Buy |
+268,000
| New | +$9.17M | 2.94% | 6 |
|